During the past decade, University of Florida Clinical Research Center conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 11 clinical trials were completed, i.e. on average, 34.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Florida Clinical Research Center" #1 sponsor was "University of Florida" with 16 trials, followed by "Purdue Pharma LP" with 5 trials sponsored, "United Therapeutics" with 5 trials sponsored, "Amicus Therapeutics" with 4 trials sponsored and "Galapagos NV" with 4 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Florida Clinical Research Center" #1 collaborator was "Friedreich's Ataxia Research Alliance" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 2 trials as a collaborator, "Thorne HealthTech, Inc" with 2 trials as a collaborator and "Amicus Therapeutics" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "University of Florida Clinical Research Center" are "Friedreich's Ataxia" (3 trials), "Pharmacokinetics" (3 trials), "Pulmonary Arterial Hypertension" (3 trials), "Pulmonary Hypertension" (3 trials) and "Back Pain" (2 trials). Many other conditions were trialed in "University of Florida Clinical Research Center" in a lesser frequency.

Most popular intervention types in "University of Florida Clinical Research Center" are "Drug" (36 trials), "Other" (7 trials), "Biological" (3 trials), "Dietary Supplement" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Buprenorphine transdermal delivery system" (4 trials), "Filgotinib" (3 trials), "Inhaled Treprostinil" (2 trials) and "Interferon γ-1b" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Florida Clinical Research Center" are 44 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Florida Clinical Research Center". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in University of Florida Clinical Research Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University of Florida Clinical Research Center, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".